148 related articles for article (PubMed ID: 10626910)
1. Low affinity binding of an LFA-3/IgG1 fusion protein to CD2+ T cells is independent of cell activation.
Majeau GR; Whitty A; Yim K; Meier W; Hochman PS
Cell Adhes Commun; 1999; 7(3):267-79. PubMed ID: 10626910
[TBL] [Abstract][Full Text] [Related]
2. Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59.
van der Merwe PA; Barclay AN; Mason DW; Davies EA; Morgan BP; Tone M; Krishnam AK; Ianelli C; Davis SJ
Biochemistry; 1994 Aug; 33(33):10149-60. PubMed ID: 7520278
[TBL] [Abstract][Full Text] [Related]
3. Specific interaction of lymphocyte function-associated antigen 3 with CD2 can inhibit T cell responses.
Miller GT; Hochman PS; Meier W; Tizard R; Bixler SA; Rosa MD; Wallner BP
J Exp Med; 1993 Jul; 178(1):211-22. PubMed ID: 7686212
[TBL] [Abstract][Full Text] [Related]
4. Alefacept, an immunomodulatory recombinant LFA-3/IgG1 fusion protein, induces CD16 signaling and CD2/CD16-dependent apoptosis of CD2(+) cells.
da Silva AJ; Brickelmaier M; Majeau GR; Li Z; Su L; Hsu YM; Hochman PS
J Immunol; 2002 May; 168(9):4462-71. PubMed ID: 11970990
[TBL] [Abstract][Full Text] [Related]
5. Adhesive bond dynamics in contacts between T lymphocytes and glass-supported planar bilayers reconstituted with the immunoglobulin-related adhesion molecule CD58.
Dustin ML
J Biol Chem; 1997 Jun; 272(25):15782-8. PubMed ID: 9188475
[TBL] [Abstract][Full Text] [Related]
6. Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor.
Bierer BE; Peterson A; Gorga JC; Herrmann SH; Burakoff SJ
J Exp Med; 1988 Sep; 168(3):1145-56. PubMed ID: 2459290
[TBL] [Abstract][Full Text] [Related]
7. CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation.
Kato K; Koyanagi M; Okada H; Takanashi T; Wong YW; Williams AF; Okumura K; Yagita H
J Exp Med; 1992 Nov; 176(5):1241-9. PubMed ID: 1383383
[TBL] [Abstract][Full Text] [Related]
8. Visualization of CD2 interaction with LFA-3 and determination of the two-dimensional dissociation constant for adhesion receptors in a contact area.
Dustin ML; Ferguson LM; Chan PY; Springer TA; Golan DE
J Cell Biol; 1996 Feb; 132(3):465-74. PubMed ID: 8636222
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of lymphocyte function-associated molecule 3-Ig fusion proteins inhibition of T cell responses. Structure/function analysis in vitro and in human CD2 transgenic mice.
Majeau GR; Meier W; Jimmo B; Kioussis D; Hochman PS
J Immunol; 1994 Mar; 152(6):2753-67. PubMed ID: 7511625
[TBL] [Abstract][Full Text] [Related]
10. Correlation of CD2 binding and functional properties of multimeric and monomeric lymphocyte function-associated antigen 3.
Dustin ML; Olive D; Springer TA
J Exp Med; 1989 Feb; 169(2):503-17. PubMed ID: 2463330
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of T cell activation and adhesion functions by soluble CD2 protein.
Rabin EM; Gordon K; Knoppers MH; Luther MA; Neidhardt EA; Flynn JF; Sardonini CA; Sampo TM; Concino MF; Recny MA
Cell Immunol; 1993 Jun; 149(1):24-38. PubMed ID: 7685660
[TBL] [Abstract][Full Text] [Related]
12. A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2: divergence of CD2 ligands during the evolution of humans and mice.
Arulanandam AR; Moingeon P; Concino MF; Recny MA; Kato K; Yagita H; Koyasu S; Reinherz EL
J Exp Med; 1993 May; 177(5):1439-50. PubMed ID: 7683037
[TBL] [Abstract][Full Text] [Related]
13. Costimulatory Function of Cd58/Cd2 Interaction in Adaptive Humoral Immunity in a Zebrafish Model.
Shao T; Shi W; Zheng JY; Xu XX; Lin AF; Xiang LX; Shao JZ
Front Immunol; 2018; 9():1204. PubMed ID: 29904386
[TBL] [Abstract][Full Text] [Related]
14. Low affinity interaction of human or rat T cell adhesion molecule CD2 with its ligand aligns adhering membranes to achieve high physiological affinity.
Dustin ML; Golan DE; Zhu DM; Miller JM; Meier W; Davies EA; van der Merwe PA
J Biol Chem; 1997 Dec; 272(49):30889-98. PubMed ID: 9388235
[TBL] [Abstract][Full Text] [Related]
15. The role of CD2/LFA-3 interaction in antigen- and mitogen-induced activation of human T cells.
Tiefenthaler G; Hünig T
Int Immunol; 1989; 1(2):169-75. PubMed ID: 2484882
[TBL] [Abstract][Full Text] [Related]
16. Stimulator cell-dependent requirement for CD2- and LFA-1-mediated adhesions in T lymphocyte activation by superantigenic toxins.
Mittrücker HW; Fleischer B
Cell Immunol; 1992 Jan; 139(1):108-17. PubMed ID: 1370253
[TBL] [Abstract][Full Text] [Related]
17. Quantification and modeling of tripartite CD2-, CD58FC chimera (alefacept)-, and CD16-mediated cell adhesion.
Dustin ML; Starr T; Coombs D; Majeau GR; Meier W; Hochman PS; Douglass A; Vale R; Goldstein B; Whitty A
J Biol Chem; 2007 Nov; 282(48):34748-57. PubMed ID: 17911103
[TBL] [Abstract][Full Text] [Related]
18. The proliferative response of human T cells to allogeneic IFN-gamma-treated endothelial cells is mediated via both CD2/LFA-3 and LFA-1/ICAM-1 and -2 adhesion pathways.
Westphal JR; Willems HW; Tax WJ; Koene RA; Ruiter DJ; de Waal RM
Transpl Immunol; 1993; 1(3):183-91. PubMed ID: 7521739
[TBL] [Abstract][Full Text] [Related]
19. Structure of a heterophilic adhesion complex between the human CD2 and CD58 (LFA-3) counterreceptors.
Wang JH; Smolyar A; Tan K; Liu JH; Kim M; Sun ZY; Wagner G; Reinherz EL
Cell; 1999 Jun; 97(6):791-803. PubMed ID: 10380930
[TBL] [Abstract][Full Text] [Related]
20. Amino acid residues required for binding of lymphocyte function-associated antigen 3 (CD58) to its counter-receptor CD2.
Osborn L; Day ES; Miller GT; Karpusas M; Tizard R; Meuer SC; Hochman PS
J Exp Med; 1995 Jan; 181(1):429-34. PubMed ID: 7528777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
